COSENTINO, Francesco
 Distribuzione geografica
Continente #
NA - Nord America 3.101
EU - Europa 2.797
AS - Asia 797
SA - Sud America 295
AF - Africa 210
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 7.202
Nazione #
US - Stati Uniti d'America 3.026
RU - Federazione Russa 1.487
IE - Irlanda 625
SG - Singapore 458
BR - Brasile 235
CI - Costa d'Avorio 175
IT - Italia 131
FI - Finlandia 110
DE - Germania 87
VN - Vietnam 81
SE - Svezia 70
UA - Ucraina 63
GB - Regno Unito 51
CN - Cina 46
IN - India 46
CA - Canada 45
BE - Belgio 39
HK - Hong Kong 36
MX - Messico 26
CZ - Repubblica Ceca 25
AR - Argentina 24
JP - Giappone 24
NL - Olanda 22
ZA - Sudafrica 18
BD - Bangladesh 17
IQ - Iraq 16
AT - Austria 15
ES - Italia 15
PL - Polonia 12
FR - Francia 11
TR - Turchia 10
EC - Ecuador 9
ID - Indonesia 8
CO - Colombia 7
PE - Perù 7
RO - Romania 7
SA - Arabia Saudita 7
EG - Egitto 6
KG - Kirghizistan 6
MA - Marocco 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
CH - Svizzera 5
PK - Pakistan 5
VE - Venezuela 5
IL - Israele 4
LT - Lituania 4
NP - Nepal 4
SK - Slovacchia (Repubblica Slovacca) 4
AL - Albania 3
LV - Lettonia 3
PH - Filippine 3
UY - Uruguay 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
CL - Cile 2
CR - Costa Rica 2
GR - Grecia 2
IR - Iran 2
KZ - Kazakistan 2
PY - Paraguay 2
TH - Thailandia 2
BF - Burkina Faso 1
BH - Bahrain 1
BI - Burundi 1
BO - Bolivia 1
BW - Botswana 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KE - Kenya 1
LA - Repubblica Popolare Democratica del Laos 1
MY - Malesia 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PS - Palestinian Territory 1
TM - Turkmenistan 1
UZ - Uzbekistan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 7.202
Città #
Dallas 1.258
Dublin 625
Chandler 469
Moscow 440
Singapore 265
Abidjan 175
Helsinki 106
Ashburn 95
Jacksonville 92
Princeton 61
Wilmington 49
Los Angeles 47
Boardman 45
San Mateo 45
New York 41
Brussels 39
Ho Chi Minh City 35
Hong Kong 34
Beijing 29
The Dalles 26
Rome 23
Brno 21
Tokyo 21
West Jordan 20
Munich 18
Atlanta 16
Ann Arbor 15
Hanoi 15
São Paulo 15
Toronto 15
Falkenstein 14
Santa Clara 14
Montreal 12
Brooklyn 11
London 11
Nuremberg 11
Stockholm 11
Chicago 10
Johannesburg 10
Mexico City 10
Orem 10
Warsaw 10
Baghdad 9
Denver 9
Phoenix 9
Assago 8
Bologna 8
Chennai 8
Frankfurt am Main 8
Poplar 8
Amsterdam 7
Boston 7
Council Bluffs 7
Norwalk 7
Ottawa 7
Belo Horizonte 6
Bishkek 6
Lima 6
Redwood City 6
Baku 5
Bangalore 5
Borås 5
Bromley 5
Casoria 5
Cleveland 5
Curitiba 5
Dhaka 5
Guarulhos 5
Haiphong 5
Houston 5
Longare 5
Milan 5
Old Bridge 5
San Francisco 5
Vienna 5
Birmingham 4
Charlotte 4
Columbus 4
Dubai 4
Lappeenranta 4
Manchester 4
Medina 4
Naples 4
Querétaro 4
Rio de Janeiro 4
Rockville 4
Timisoara 4
Ankara 3
Brasília 3
Bratislava 3
Buenos Aires 3
Canoas 3
Da Nang 3
Fortaleza 3
Garden City 3
Goiânia 3
Guangzhou 3
Guayaquil 3
Istanbul 3
Jakarta 3
Totale 4.582
Nome #
Minimally invasive surgical treatment of recurrent endometrial carcinoma: A systematic review 751
Arterial-enteric fistula after pelvic lymphadenectomy in secondary cytoreductive surgery for recurrent ovarian cancer. 126
Could lymphadenectomy be avoided in locally advanced cervical cancer patients administered preoperative chemoradiation? A large-scale retrospective study 115
Definition of a dynamic laparoscopic model for the prediction of incomplete cytoreduction in advanced epithelial ovarian cancer: Proof of a concept 115
Feasibility, safety, and efficacy of conservative laparoscopic treatment of borderline ovarian tumors 115
Impact of surgeon learning curve in minimally invasive radical hysterectomy on early stage cervical cancer patient survival 109
How to Select Early-Stage Cervical Cancer Patients Still Suitable for Laparoscopic Radical Hysterectomy: a Propensity-Matched Study 106
A Multicentric Randomized Trial to Evaluate the ROle of Uterine MANipulator on Laparoscopic/Robotic HYsterectomy for the Treatment of Early-Stage Endometrial Cancer: The ROMANHY Trial 106
Feasibility, morbidity, and safety of total laparoscopic radical hysterectomy with lymphadenectomy: our experience 104
Neoadjuvant Chemoradiotherapy Treatment With Intensity-Modulated Technique (VMAT/IMRT), Simultaneous Integrated Boost (SIB), And Image-Guided Radiotherapy (IGRT) Followed By Radical Surgery In Locally Advanced Cervical Cancer: Prospective Phase II Study (LARA 4.0) 101
Feasibility and safety of two different surgical routes for the eradication of recto-vaginal endometriosis with vaginal mucosa infiltration (Endo-Vag-r study). 101
Different Surgical Approaches for Early-Stage Ovarian Cancer Staging. A Large Monocentric Experience 100
A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessment A laparoscopic risk-adjusted model to predict major complications after primary debulking surgery in ovarian cancer: A single-institution assessment 99
Efficacy of Corticosteroids in Patients With Recurrent Pregnancy Loss: A Systematic Review and Meta-Analysis 97
ROBOTIC VERSUS LAPAROSCOPIC RADICAL HYSTERECTOMY FOR EARLY CERVICAL CANCER: A CASE MATCHED CONTROL STUDY 95
Clinical Impact of Pathologic Residual Tumor in Locally Advanced Cervical Cancer Patients Managed by Chemoradiotherapy Followed by Radical Surgery: A Large, Multicenter, Retrospective Study 93
Investigating the possible impact of peritoneal tumor exposure amongst women with early stage cervical cancer treated with minimally invasive approach 92
Modern chemoradiation followed by radical surgery in patients with locally advanced cervical cancer: the LARA 4 phase II study 90
A large multicenter propensity match study of sentinel lymph node biopsy feasibility in endometrioid variants of endometrial cancer 88
Evaluation of molecular signature predictive power for response to neoadjuvant chemoradiotherapy in patients with locally advanced cervical cancer 86
Subcutaneous Vulvar Flap Viability Evaluation With Near-Infrared Probe and Indocyanine Green for Vulvar Cancer Reconstructive Surgery: A Feasible Technique 85
Three-Dimensional Versus Two Dimensional Radical Laparoscopic Hysterectomy for Endometrial and Cervical Cancer: A Prospective Randomized Trial 84
Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage ovarian cancer: A prospective multicentre study (SELLY). 81
Surgical outcomes of diaphragmatic resection during cytoreductive surgery for advanced gynecological ovarian neoplasia: A randomized single center clinical trial - DRAGON. 80
Laparoscopic discoid rectal resection as surgical treatment of endometrial cancer recurrence 79
Retrospective Investigator-Initiated Trial on Tocopherol Acetate Vaginal Administration in Pre-and Postmenopausal Women 78
Laparoscopic radical hysterectomy with lymphadenectomy in patients with early cervical cancer: Our instruments and technique 78
Minimally Invasive Approaches in Locally Advanced Cervical Cancer Patients Undergoing Radical Surgery After Chemoradiotherapy: A Propensity Score Analysis 78
Infiltrating T lymphocytes and programmed cell death protein-1/programmed death-ligand 1 expression in endometriosis-associated ovarian cancer 78
Extreme complications related to bevacizumab use in the treatment of ovarian cancer: a case series from a III level referral centre and review of the literature 78
Minimally invasive interval debulking surgery in ovarian neoplasm (MISSION trialeNCT02324595): a feasibility study 75
Should the Number of Metastatic Pelvic Lymph Nodes be Integrated into the 2018 Figo Staging Classification of Early Stage Cervical Cancer? 75
Investigating the possible impact of peritoneal tumor exposure amongst women with early stage cervical cancer treated with minimally invasive approach. 75
Laparoscopy versus minilaparotomy in women with symptomatic uterine myomas: short-term and fertility results 74
Laparoscopic Management of Abdominal Pregnancy 73
Neoadjuvant Chemotherapy Followed by Maintenance Therapy With or Without Bevacizumab in Unresectable High-Grade Serous Ovarian Cancer: A Case-Control Study 73
Is early stage endometrial cancer safely treated by laparoscopy? Complications of a multicenter study and review of recent literature 73
Impact of Obesity on Sentinel Lymph Node Mapping in Patients with apparent Early-Stage Endometrial Cancer: The ObeLyX study 72
Rare Case of Endoscopic Treatment for Bevacizumab-Related Gastric Perforation in a Patient with Ovarian Cancer. 71
Minimally Invasive Surgery Resection Of Recurrent Endometrial Carcinoma Metastasis: A Systematic Review 71
Randomized trial of primary debulking surgery versus neoadjuvant chemotherapy for advanced epithelial ovarian cancer (SCORPION-NCT01461850) 70
Pre-operative risk factors of concomitant endometrial carcinoma in women with hysteroscopic diagnosis of complex atypical hyperplasia: a multicenter study 69
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome 68
Laparotomy approach to sentinel lymph node detection in ovarian cancer using a near-infrared fluorescent system camera with indocyanine green dye 67
Concurrent endometrial cancer in atypical endometrial hyperplasia and the role of sentinel lymph nodes: clinical insights from a multicenter experience 66
Horizontal versus vertical direction of posterior vaginal wall suture after eradication of rectovaginal endometriosis: A multicenter study 66
Long-term evaluation of quality of life and gastrointestinal well-being after segmental colo-rectal resection for deep infiltrating endometriosis (ENDO-RESECT QoL). 66
Minilaparoscopic radical hysterectomy for cervical cancer: Multi-institutional experience in comparison with conventional laparoscopy 66
Real three-dimensional approach vs two-dimensional camera with and without real-time near-infrared imaging with indocyanine green for detection of endometriosis: A case-control study. 65
Laparoscopic Staging of Early Ovarian Cancer: Results of a Multi-Institutional Cohort Study 65
Upfront HIPEC and bevacizumab-containing adjuvant chemotherapy in advanced epithelial ovarian cancer 64
Sentinel Lymph Node in Aged Endometrial Cancer Patients "The SAGE Study": A Multicenter Experience 64
Sentinel-node biopsy in early stage ovarian cancer: a prospective multicentre study (SELLY) 63
Robotic versus laparoscopic radical hysterectomy in early cervical cancer: A case matched control study 63
Role of minimally invasive surgery versus open approach in patients with early-stage uterine carcinosarcomas: a retrospective multicentric study 63
Total laparoscopic hysterectomy for enlarged uteri: factors associated with the rate of conversion to open surgery 63
Indocyanine green fluorescence angiography after full-thickness bowel resection for recto-sigmoid endometriosis: a multicentric experience with quantitative analysis 63
Minimally Invasive Approaches in Locally Advanced Cervical Cancer Patients Undergoing Radical Surgery After Chemoradiotherapy: A Propensity Score Analysis 62
Efficacy of postoperative patient controlled epidural analgesia in the management of acute post-operative pain control in gynecological cancer patient a network meta-analysis 61
Total Laparoscopic Radical Hysterectomy Versus Abdominal Radical Hysterectomy with Lymphadenectomy in Patients with Early Cervical Cancer: Our Experience 61
Management, prognosis and reproductive outcomes of borderline ovarian tumor relapse during pregnancy: from diagnosis to potential treatment options 61
Indocyanine green in the surgical management of endometriosis: A systematic review. 60
Total laparoscopic hysterectomy versus abdominal hysterectomy with lymphadenectomy for early-stage endometrial cancer: a prospective randomized study 60
Laparoscopic Versus Open Radical Hysterectomy for Stage IB2–IIB Cervical Cancer in the Setting of Neoadjuvant Chemotherapy: A Multi-institutional Cohort Study 59
Sexual function and quality of life of patients affected by ovarian cancer 59
Sentinel-node biopsy in early-stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY). 59
Surgery-related complications and long-term functional morbidity after segmental colo-rectal resection for deep infiltrating endometriosis (ENDO-RESECT morb). 59
Near-Infrared Imaging with Indocyanine Green for Detection of Endometriosis Lesions (Gre-Endo Trial): a Pilot Study 58
Near-Infrared Imaging With Indocyanine Green for the Treatment of Endometriosis: Results From the Gre-Endo Trial 58
Secondary cytoreductive surgery in endometrial cancer recurrence: how to triage patients towards surgery, a multicenter study 57
Robotics Versus Laparoscopic Radical Hysterectomy with Lymphadenectomy in Patients with Early Cervical Cancer: A Multicenter Study 57
Neo-adjuvant platinum-based chemotherapy followed by chemoradiation and radical surgery in locally advanced cervical cancer (Lacc) patients: A phase II study 56
Patterns of recurrence in FIGO 2018 stage IB1-IB2 cervical cancer comparison between minimally invasive and abdominal radical hysterectomy EJSO 55
Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery 54
Value of indocyanine green and laparoscopic near-infrared technology in the surgical management of endometriosis: What is the evidence? 53
The role of sentinel lymph node biopsy in the management of patients with endometrial atypical hyperplasia: a multicenter study 51
Sentinel-node biopsy in early stage ovarian cancer: preliminary results of a prospective multicentre study (SELLY) Conference Paper Nov 2023 50
Port Site Metastasis in Women with Low- or Intermediate-Risk Endometrial Carcinoma: A Systematic Review of Literature 49
Prevalence of sonographic signs in women with uterine sarcoma: a systematic review and meta-analysis 49
Telelap ALF-X vs Standard Laparoscopy for the Treatment of Early-Stage Endometrial Cancer: A Single-Institution Retrospective Cohort Study 49
Minimally invasive surgery in recurrent endometrial cancer a multicenter study 45
Major determinants of survival in recurrent endometrial cancer: The role of secondary cytoreductive surgery and relapse pattern. A Multicenter Study 45
Long-term survival outcomes in high-risk endometrial cancer patients undergoing sentinel lymph node biopsy vs. lymphadenectomy 45
Preoperative Tumor Texture Analysis on MRI for High-Risk Disease Prediction in Endometrial Cancer: A Hypothesis-Generating Study 44
TREATMENT OF OLIGOMETASTATIC PARENCHYMAL LESIONS IN OVARIAN CANCER WITH STEREOTACTIC ABLATIVE RADIOTHERAPY: A MULTICENTER PROSPECTIVE PHASE II TRIAL (MITO RT3/RAD) 43
Is the sarcomatous component (homologous vs heterologous) the prognostic "driving force" in early-stage uterine carcinosarcomas? A retrospective multicenter study 43
Hysteroscopic endometrial tumor localization and sentinel lymph node mapping. An upgrade of the hysteroscopic role in endometrial cancer patients 43
Laparoscopic treatment of ovarian granulosa cells tumor developed in the pelvic anterior preperitoneal space 20 years after laparotomic salpingo-oophorectomy: case report and review of literature. 43
Long-term survival outcomes in high-risk endometrial cancer patients undergoing sentinel lymph node biopsy alone versus lymphadenectomy 40
Secondary cytoreductive surgery in endometrial cancer recurrence: a preoperative prediction model for complete gross resection 40
SENTINEL-NODE BIOPSY IN APPARENT EARLY STAGE OVARIAN CANCER: FINAL RESULTS OF A PROSPECTIVE MULTICENTRE STUDY (SELLY) 38
Major determinants of survival in recurrent endometrial cancer-the role of secondary cytoreductive surgery: a multicenter study 37
Optimizing patient selection for secondary cytoreductive surgery in recurrent endometrial cancer 34
Sentinel node mapping, sentinel node mapping plus back-up lymphadenectomy, and lymphadenectomy in Early-sTage cERvical caNcer scheduled for fertilItY-sparing approach: The ETERNITY project 33
Where Morphological and Molecular Classifications Meet: The Role of p53 Immunohistochemistry in the Prognosis of Low-Risk Endometrial Carcinoma (GLAMOUR Study) 31
Pattern of recurrence in endometrial cancer. The murderer always returns to the scene of the crime 30
Human papillomavirus independent status on pathologic response and outcomes in locally advanced cervical cancer managed with chemoradiotherapy followed by surgery. 30
Chemo-conization in Early-sTage cERvical caNcer >2 cm scheduled for fertilItY-sparing approach: an analysis of the ETERNITY project 29
D'Ippolito S, Pasciuto T, Granieri C, Giuliano S, Barbaro G, Pianese G, Martino C, Tersigni C, Colalillo A, Catena U, Greco P, Vizzielli G, Ghi T, Cosentino F, Di Simone N 28
STEREOTACTIC ABLATIVE RADIOTHERAPY FOR OLIGOMETASTATIC OVARIAN CANCER LYMPH NODE DISEASE: THE MITO-RT3/RAD PHASE II TRIAL: stereotactic radiotherapy for ovarian cancer nodal metastases 24
Totale 7.373
Categoria #
all - tutte 39.196
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 39.196


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021259 0 0 0 0 0 106 47 0 46 1 47 12
2021/2022319 4 45 12 6 34 19 9 44 56 60 13 17
2022/20231.620 199 83 28 140 65 135 3 103 748 62 24 30
2023/2024315 75 17 23 6 10 46 8 17 18 27 7 61
2024/20251.293 234 57 167 12 178 18 17 74 152 29 141 214
2025/20263.596 150 877 554 355 1.291 369 0 0 0 0 0 0
Totale 7.407